Tandem will integrate its insulin delivery systems with a new dual glucose-ketone sensor being developed by Abbott.

Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The ...

Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in emerging markets.

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

The smart insulin pens market represents a significant advancement in diabetes management technology, providing a modern solution to a longstanding health challenge. These devices combine traditional ...

Although insulin makers ... who needed type 1 diabetes treatment in these 71 countries were covered by access initiatives from the large insulin manufacturers — Eli Lilly, Novo Nordisk, and ...

The Mobi miniature, durable automated insulin patch pump worn on a hiker’s leg. [Image courtesy of Tandem Diabetes Care] Tandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K to state that it ...